Skip to main content
UniHealth

Doctor search

Gelareh Homayounfar, MD

Dermatology · Mountain View

NPI 1598178626

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
14
2 carriers
Office
1

Offices

1 location · Sutter Bay Medical Foundation · 3,783 clinicians in this group

Looking this up.

Plans that list them

14 plans · 2 carriers

A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Homayounfar’s office at (650) 691-6174 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.

14 of 14 plans

Plans whose provider directory lists this clinician
Alignment Health BreathEasy (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Clarity (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Harmony (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes CalPlus (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes Care (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Heart & Diabetes Choice (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Honor+ Plan (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health My Choice CalCare (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health Silicon (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Sutter Advantage +More (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health smartHMO (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health the ONE (HMO)Alignment Health PlanListedOct 3, 2026
DualConnect (HMO D-SNP)Santa Clara Family Health PlanListedSep 1, 2026

California Medical Board record

Licence A153765 · Current

Licensed to practise in California · since 2018 · expires 2027-12-31 · Harvard Medical School.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

Original Medicare doctor bills

$134,477

Medicare paid this office $134,477 for 403 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Short return visit (20+ min)251$30,202$75
Return visit (30+ min)165$27,399$110
Biopsy of related skin growth, first growth182$22,472$90
Destruction of skin growth, 1-14 growths85$13,247$111
Destruction of precancer skin growth, 1 growth154$11,366$46
See all 12 services
Every Original Medicare service billed
Short return visit (20+ min)251$30,202$75
Return visit (30+ min)165$27,399$110
Biopsy of related skin growth, first growth182$22,472$90
Destruction of skin growth, 1-14 growths85$13,247$111
Destruction of precancer skin growth, 1 growth154$11,366$46
Biopsy of related skin growth, each additional growth63$5,150$52
Punch biopsy, first skin growth36$5,011$128
Destruction of precancer skin growth, 2-14 growths113$4,809$7
New patient visit (30+ min)36$3,409$95
Application of ultraviolet light to skin17$3,106$28
New patient visit (45+ min)20$2,771$139
Short return visit12$617$51

Procedures Medicare counted

Procedure volume Medicare published
Removal of skin lesions585More than 88% of doctors who do this
Removal or shaving of skin growth23More than 72% of doctors who do this
Skin biopsy313More than 91% of doctors who do this

Who their Medicare patients are

403 Original Medicare patients in 2024. Average age 75 · Under 65 3% · 85 and older 12% · Women 55% · Also on Medicaid 6% · Health risk score 0.87. At or below the middle of the specialty; the typical dermatology clinician is at 1.01.

Conditions among them: High blood pressure 57% · Chronic kidney disease 18% · Cancer 18% · Diabetes 17% · Coronary heart disease 16% · Depression 14% · Atrial fibrillation 9% · Heart failure 7% · Dementia 5% · COPD 4% · Stroke 4%.

The office billed $490,169, Medicare allowed $186,471 and paid $134,477; for 2,331 services of 27 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
20244032,331750.87$490,169$134,477
20233931,986750.88$404,516$116,220
20223711,460750.82$287,746$83,068
2021200607750.87$132,362$37,982
20202891,062751.08$195,860$52,023
2019179530741.05$108,055$31,232

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 12 services

Original Medicare services billed in 2023
Short return visit (20+ min)226$23,215$76
Return visit (30+ min)141$22,893$112
Biopsy of related skin growth, first growth168$20,784$99
Destruction of precancer skin growth, 1 growth148$10,255$50
Destruction of skin growth, 1-14 growths45$6,014$116
Destruction of precancer skin growth, 2-14 growths114$4,439$7
Biopsy of related skin growth, each additional growth66$4,407$52
New patient visit (30+ min)40$4,165$104
Punch biopsy, first skin growth29$3,922$131
New patient visit (45+ min)24$3,809$159
Application of ultraviolet light to skin20$3,518$28
Short return visit14$850$57

2022: 12 services

Original Medicare services billed in 2022
Short return visit (20+ min)171$15,683$73
Biopsy of related skin growth, first growth124$15,505$103
Return visit (30+ min)107$14,708$109
Destruction of precancer skin growth, 1 growth117$6,870$48
Destruction of skin growth, 1-14 growths27$3,717$113
New patient visit (45+ min)26$3,688$142
New patient visit (30+ min)39$3,364$86
Destruction of precancer skin growth, 2-14 growths88$3,138$7
Biopsy of related skin growth, each additional growth40$3,026$54
Application of ultraviolet light to skin21$2,737$27
New patient visit (15+ min)15$864$58
Short return visit19$816$43

2021: 8 services

Original Medicare services billed in 2021
Return visit (30+ min)67$8,280$106
Short return visit (20+ min)77$6,423$75
Biopsy of related skin growth, first growth43$4,916$98
Destruction of precancer skin growth, 1 growth52$2,890$49
New patient visit (30+ min)21$1,853$88
New patient visit (45+ min)13$1,754$135
Biopsy of related skin growth, each additional growth17$1,213$51
Destruction of precancer skin growth, 2-14 growths37$1,064$7

2020: 10 services

Original Medicare services billed in 2020
Biopsy of related skin growth, first growth94$9,733$88
Short return visit (20+ min)133$9,670$59
Destruction of precancer skin growth, 1 growth87$5,631$47
Return visit (30+ min)56$5,100$88
New patient visit (15+ min)67$3,674$55
Short return visit75$3,137$36
Biopsy of related skin growth, each additional growth28$2,139$52
Destruction of skin growth, 1-14 growths19$2,082$99
Destruction of precancer skin growth, 2-14 growths58$1,647$6
Punch biopsy, first skin growth11$1,442$131

2019: 9 services

Original Medicare services billed in 2019
Short return visit (20+ min)79$5,932$71
Biopsy of related skin growth, first growth54$5,753$94
New patient visit (15+ min)48$3,186$66
Destruction of skin growth, 1-14 growths23$2,773$107
Destruction of precancer skin growth, 1 growth45$2,621$51
New patient visit (30+ min)22$2,087$95
Short return visit22$1,183$44
Biopsy of related skin growth, each additional growth12$749$53
Destruction of precancer skin growth, 2-14 growths32$748$6

Drugs they prescribed that Part D paid

$618,406

Pharmacies billed $618,406 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 0% of their Part D prescriptions (0 of 717) in 2024. At or below the middle of the specialty; the typical dermatology clinician is at 0%.

642 generic and 75 brand-name prescriptions · $618,406 in drug cost · 38 antibiotic prescriptions to 22 people.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Stelara15$299,386$19,959
Humira(Cf)12$159,697$13,308
Humira13$86,610$6,662
Tacrolimus24$5,182$216
Betamethasone Dipropionate32$2,437$76
See all 20 drugs
Every Part D drug this clinician prescribed
Stelara15$299,386$19,959
Humira(Cf)12$159,697$13,308
Humira13$86,610$6,662
Tacrolimus24$5,182$216
Betamethasone Dipropionate32$2,437$76
Clindamycin Phosphate25$2,318$93
Ketoconazole141$2,108$15
Calcipotriene20$2,086$104
Fluocinonide50$1,645$33
Clobetasol Propionate28$1,190$42
Fluorouracil22$1,133$51
Tretinoin11$945$86
Ciclopirox34$888$26
Metronidazole17$820$48
Betamethasone Diprop Augmented24$615$26
Triamcinolone Acetonide50$532$11
Doxycycline Hyclate21$491$23
Hydrocortisone47$353$8
Doxycycline Monohydrate16$228$14
Mupirocin30$195$7

Year by year

Part D prescribing by year
20247172370% (0)10%$618,406
20236612260% (0)9%$423,110
20225072000% (0)9%$214,241
20212931190% (0)9%$162,211
20204091350% (0)8%$120,583
2019111550% (0)None$3,842
201895310% (0)None$7,027
2017147440% (0)17%$24,976
201642170% (0)None$4,902
20153914NoneNone$3,243
20143914NoneNone$2,035

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 17 drugs

Part D drugs prescribed in 2023
Stelara13$268,148$20,627
Ketoconazole132$3,776$29
Tacrolimus17$3,502$206
Betamethasone Dipropionate29$2,780$96
Clindamycin Phosphate27$2,668$99
Fluocinonide46$2,599$56
Calcipotriene21$2,381$113
Clobetasol Propionate31$2,017$65
Fluorouracil27$1,860$69
Ciclopirox23$1,086$47
Betamethasone Diprop Augmented24$910$38
Doxycycline Hyclate22$665$30
Triamcinolone Acetonide48$538$11
Hydrocortisone58$395$7
Mupirocin33$352$11
Mometasone Furoate13$225$17
Finasteride11$79$7

2022: 16 drugs

Part D drugs prescribed in 2022
Calcipotriene22$3,198$145
Fluorouracil25$2,798$112
Tacrolimus16$2,776$173
Ketoconazole102$2,675$26
Fluocinonide51$2,537$50
Betamethasone Dipropionate18$1,378$77
Clobetasol Propionate15$1,119$75
Betamethasone Diprop Augmented13$1,097$84
Doxycycline Hyclate19$818$43
Metronidazole13$781$60
Ciclopirox11$665$60
Triamcinolone Acetonide49$501$10
Clindamycin Phosphate12$455$38
Mometasone Furoate24$319$13
Mupirocin21$278$13
Hydrocortisone34$265$8

2021: 9 drugs

Part D drugs prescribed in 2021
Ketoconazole56$1,339$24
Fluocinonide29$1,269$44
Clobetasol Propionate15$685$46
Valacyclovir11$675$61
Triamcinolone Acetonide46$657$14
Ciclopirox12$342$29
Doxycycline Hyclate15$321$21
Mupirocin21$192$9
Hydrocortisone12$83$7

2020: 10 drugs

Part D drugs prescribed in 2020
Ketoconazole100$2,561$26
Fluocinonide43$2,355$55
Calcipotriene11$1,261$115
Clobetasol Propionate11$744$68
Clindamycin Phosphate12$700$58
Triamcinolone Acetonide50$606$12
Ciclopirox15$495$33
Valacyclovir11$399$36
Mupirocin42$386$9
Hydrocortisone41$240$6

2019: 3 drugs

Part D drugs prescribed in 2019
Ketoconazole31$795$26
Fluocinonide13$757$58
Triamcinolone Acetonide18$135$7

2018: 2 drugs

Part D drugs prescribed in 2018
Ketoconazole25$1,096$44
Triamcinolone Acetonide19$289$15

2017: 4 drugs

Part D drugs prescribed in 2017
Ketoconazole35$1,572$45
Fluocinolone Acetonide13$1,524$117
Clindamycin Phosphate11$1,010$92
Triamcinolone Acetonide24$273$11

Money from drug and device companies

$900 in 2025

Industry payments by year
20251433None$900
20241129None$862

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
GenzymeDupixent$130
3 payments
  • Meals for Dupixent · 2025-10-20 · $47
  • Meals for Dupixent · 2025-05-20 · $41
  • Meals for Dupixent · 2025-02-03 · $42
Janssen BiotechTremfya$127
5 payments
  • Meals for Tremfya · 2025-09-15 · $14
  • Meals for Tremfya · 2025-08-04 · $23
  • Meals for Tremfya · 2025-07-14 · $34
  • Meals for Tremfya · 2025-05-06 · $25
  • Meals for Tremfya · 2025-01-17 · $30
Galderma Laboratories L.P.Nemluvio$86
4 payments
  • Meals for Nemluvio · 2025-10-27 · $26
  • Meals · 2025-08-11 · $18
  • Meals for Nemluvio · 2025-08-04 · $23
  • Meals for Nemluvio · 2025-05-19 · $19
Sanofi-Aventis U.S.Dupixent$85
1 payment
  • Education for Dupixent · 2025-03-04 · $85
IncyteOpzelura$84
4 payments
  • Meals for Opzelura · 2025-12-02 · $17
  • Meals for Opzelura · 2025-11-04 · $26
  • Meals for Opzelura · 2025-06-04 · $16
  • Meals for Opzelura · 2025-02-05 · $24
Novartis PharmaceuticalsCosentyx$66
3 payments
  • Meals for Rhapsido · 2025-10-09 · $21
  • Meals for Cosentyx · 2025-05-08 · $18
  • Meals for Cosentyx · 2025-01-28 · $27
See all 33 published payments
Every published payment
IncyteMeals · 2025-12-02Opzelura$17
PfizerMeals · 2025-12-02Cibinqo$30
IncyteMeals · 2025-11-04Opzelura$26
Galderma Laboratories L.P.Meals · 2025-10-27Nemluvio$26
GenzymeMeals · 2025-10-20Dupixent$47
Lilly USAMeals · 2025-10-13Taltz$32
Novartis PharmaceuticalsMeals · 2025-10-09Rhapsido$21
Arcutis BiotherapeuticsMeals · 2025-09-16Zoryve$19
Janssen BiotechMeals · 2025-09-15Tremfya$14
Galderma Laboratories L.P.Meals · 2025-08-11None$18
Janssen BiotechMeals · 2025-08-04Tremfya$23
Galderma Laboratories L.P.Meals · 2025-08-04Nemluvio$23
OrganonMeals · 2025-07-22Vtama$26
Revance TherapeuticsMeals · 2025-07-22Daxi$30
Arcutis BiotherapeuticsMeals · 2025-07-22Zoryve$16
Janssen BiotechMeals · 2025-07-14Tremfya$34
AbbvieMeals · 2025-07-01Skyrizi$17
IncyteMeals · 2025-06-04Opzelura$16
GenzymeMeals · 2025-05-20Dupixent$41
Galderma Laboratories L.P.Meals · 2025-05-19Nemluvio$19
Novartis PharmaceuticalsMeals · 2025-05-08Cosentyx$18
Janssen BiotechMeals · 2025-05-06Tremfya$25
Lilly USAMeals · 2025-04-28Taltz$25
Arcutis BiotherapeuticsMeals · 2025-04-14Zoryve$18
OrganonMeals · 2025-03-17Hadlima$34
Sanofi-Aventis U.S.Education · 2025-03-04Dupixent$85
AlmirallMeals · 2025-02-11Klisyri$19
IncyteMeals · 2025-02-05Opzelura$24
GenzymeMeals · 2025-02-03Dupixent$42
Novartis PharmaceuticalsMeals · 2025-01-28Cosentyx$27
AbbvieMeals · 2025-01-21Skyrizi$35
Janssen BiotechMeals · 2025-01-17Tremfya$30
E.R. Squibb & Sons L.L.C.Meals · 2025-01-13Sotyktu$22
See earlier years (2024)

2024: $862

Payments by company in 2024
E.R. Squibb & Sons L.L.C.Sotyktu$157
6 payments
  • Meals for Sotyktu · 2024-12-10 · $3
  • Meals for Sotyktu · 2024-12-10 · $23
  • Meals for Sotyktu · 2024-10-28 · $35
  • Meals for Sotyktu · 2024-09-30 · $32
  • Meals for Sotyktu · 2024-06-03 · $34
  • Meals for Sotyktu · 2024-05-06 · $31
Janssen BiotechTremfya$138
2 payments
  • Meals for Tremfya · 2024-11-09 · $13
  • Meals for Tremfya · 2024-07-09 · $125
GenzymeDupixent$115
3 payments
  • Meals for Dupixent · 2024-10-31 · $42
  • Meals for Dupixent · 2024-08-27 · $32
  • Meals for Dupixent · 2024-07-08 · $41
IncyteOpzelura$105
4 payments
  • Meals for Opzelura · 2024-12-17 · $27
  • Meals for Opzelura · 2024-11-19 · $26
  • Meals for Opzelura · 2024-10-23 · $26
  • Meals for Opzelura · 2024-09-10 · $26
Arcutis BiotherapeuticsZoryve$88
4 payments
  • Meals for Zoryve · 2024-11-22 · $21
  • Meals for Zoryve · 2024-09-23 · $18
  • Meals for Zoryve · 2024-09-09 · $22
  • Meals for Zoryve · 2024-08-30 · $26
Regeneron Healthcare SolutionsDupixent$81
3 payments
  • Meals for Libtayo · 2024-10-29 · $37
  • Meals for Dupixent · 2024-10-15 · $17
  • Meals for Dupixent · 2024-09-17 · $27
Lilly USATaltz$58
2 payments
  • Meals for Taltz · 2024-12-03 · $33
  • Meals for Taltz · 2024-10-21 · $25
Novartis PharmaceuticalsCosentyx$50
2 payments
  • Meals for Cosentyx · 2024-11-05 · $23
  • Meals for Cosentyx · 2024-10-01 · $27
Galderma Laboratories L.P.None$25
1 payment
  • Meals · 2024-10-08 · $25
PfizerLitfulo$25
1 payment
  • Meals for Litfulo · 2024-11-04 · $25
AlmirallKlisyri$20
1 payment
  • Meals for Klisyri · 2024-12-16 · $20

Professional record

NPI
1598178626
Licence
CA A153765California A153765: Current · expires 2027-12-31
Trained
Harvard Medical School, 2014
Video visits
Lists video visits
Gender
Female
More record details
Sole proprietor
No
Taxonomy
Federal specialty code 207N00000X (207N00000X)
Mailing address
325 Distel Cir, Los Altos, CA, 94022
NPI first listed
2014-06-05
NPI last updated
2019-07-22

This is when the NPI record was last certified, not a medical board exam.